Cytek BioSciences, Inc. (CTKB) Social Stream
CYTEK BIOSCIENCES INC (CTKB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CTKB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 2 | $27 | $27 | $27 | $8.34 | 223.74% |
| 2022-01-06 | 3 | $27 | $20 | $23.5 | $8.34 | 181.77% |
| 2022-02-25 | 3 | $20 | $18 | $19 | $8.34 | 127.82% |
| 2022-02-28 | 3 | $18 | $17 | $17.5 | $8.34 | 109.83% |
| 2022-05-12 | 3 | $17 | $11 | $14 | $8.34 | 67.87% |
| 2022-05-16 | 3 | $12 | $11 | $11.5 | $8.34 | 37.89% |
| 2022-07-19 | 4 | $15 | $11 | $12.666 | $8.34 | 51.87% |
| 2022-08-12 | 4 | $17 | $12 | $14.666 | $8.34 | 75.85% |
| 2022-11-10 | 3 | $17 | $15 | $16 | $8.34 | 91.85% |
| 2022-11-13 | 3 | $18 | $15 | $16.666 | $8.34 | 99.83% |
| 2022-11-14 | 3 | $17 | $15 | $16.333 | $8.34 | 95.84% |
| 2022-12-14 | 4 | $17 | $15 | $16.5 | $8.34 | 97.84% |
| 2023-03-02 | 4 | $17 | $14 | $15.5 | $8.34 | 85.85% |
| 2023-03-06 | 4 | $17 | $14 | $15 | $8.34 | 79.86% |
| 2023-04-11 | 4 | $17.001 | $14 | $15 | $8.34 | 79.86% |
| 2023-06-28 | 4 | $17.001 | $12 | $14.25 | $8.34 | 70.86% |
| 2023-08-15 | 5 | $17.001 | $12 | $14.25 | $8.34 | 70.86% |
| 2023-10-15 | 5 | $17.001 | $10 | $13 | $8.34 | 55.88% |
| 2023-10-24 | 5 | $17.001 | $8 | $11.75 | $8.34 | 40.89% |
| 2023-11-08 | 5 | $12 | $8 | $10.5 | $8.34 | 25.9% |
| 2023-12-17 | 5 | $12 | $8 | $10.75 | $8.34 | 28.9% |
The Trend in the Analyst Price Target
Over the past 31 weeks, CTKB's average price target has gone down $3.5.
Over the past 41 weeks, CTKB's average upside potential has been 73.92%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-02 | 4 | 17.000 | 14 | 15.50 | 9.64 | 60.79% |
| 2023-03-06 | 4 | 17.000 | 14 | 15.00 | 10.15 | 47.78% |
| 2023-04-11 | 4 | 17.001 | 14 | 15.00 | 9.55 | 57.07% |
| 2023-10-15 | 5 | 17.001 | 10 | 13.00 | 5.02 | 158.96% |
| 2023-10-24 | 5 | 17.001 | 8 | 11.75 | 4.75 | 147.37% |
CTKB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 3 | 0 | 2 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
CTKB's average broker recommendation rating worsened by 0.3 over the prior 52 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CTKB has a higher number of analysts covering the stock than 282.89% of all US stocks.
- To contextualize these metrics, consider that out of Measuring and Control Equipment stocks, CYTEK BIOSCIENCES INC's average analyst price target is higher than 260.86% of them.
- In the context of Healthcare stocks, CYTEK BIOSCIENCES INC's variance in analysts' estimates is lower than -333.78% of them.
- CTKB has a higher upside potential (average analyst target price relative to current price) than 1833.15% of Measuring and Control Equipment stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Measuring and Control Equipment industry with the ratings most similar to CYTEK BIOSCIENCES INC are NVMI, CAMT, and COHR.
View All Top Stocks by Price Target
Is CTKB a Buy, Hold or Sell? See the POWR Ratings now!